Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Multifiling Mitra Indonesia Tbk. (MFMI)

UBC Medical Indonesia Tbk.Trading
Multifiling Mitra Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Multifiling Mitra Indonesia Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp174 (kapitalisasi pasar 691,25 M, volume 24 jam 635,5 rb), sedangkan Multifiling Mitra Indonesia Tbk. diperdagangkan di Rp1.300 (kapitalisasi pasar 984,86 M). Perbedaan utamanya: Multifiling Mitra Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

LABSMFMI
Kapitalisasi Pasar
691,25 M984,86 M
Volume
635,5 rb
Lot
6,36 rb
Perputaran
110,15 jt
Harga Rata-rata
173,33
Nilai Transaksi
110,15 jt
Harga Ekuilibrium Indikatif
174
Volume Ekuilibrium Indikatif
50

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
MFMI
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Multifiling Mitra Indonesia Tbk.

PT Multifiling Mitra Indonesia Tbk (the Company) was established based on the Notarial Deed No. 157 of Misahardi Wilamarta, SH., dated July 9, 1992. MMI is a joint venture company between PT.Multipolar Corp. Tbk. and PT. Lippo Karawaci Tbk, currently serving its customers in 4-big city, Jakarta, Surabaya, Medan dan Bandung.

Selengkapnya di halaman MFMI